XML 118 R95.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investments in Associates - Summary of Investments in Associates (Parenthetical) (Details) - CAD ($)
3 Months Ended 12 Months Ended
Dec. 08, 2017
Nov. 27, 2017
Dec. 21, 2016
Sep. 30, 2017
Mar. 31, 2018
Mar. 31, 2017
Disclosure Of Significant Investments In Associates [Line Items]            
Percentage of voting equity interests acquired         0.00%  
Investments in associates         $ 63,106,000 $ 0
Radicle Medical Marijuana Inc            
Disclosure Of Significant Investments In Associates [Line Items]            
Interest rate of debenture         5.00%  
Royalty term         20 years  
Amount advanced under convertible debenture         $ 5,000,000  
Amount advanced under repayable debenture         3,000,000  
Radicle Medical Marijuana Inc | Convertible Debenture            
Disclosure Of Significant Investments In Associates [Line Items]            
Investments in associates         5,000,000  
Radicle Medical Marijuana Inc | Repayable Debenture            
Disclosure Of Significant Investments In Associates [Line Items]            
Investments in associates         5,000,000  
TerrAscend Corp            
Disclosure Of Significant Investments In Associates [Line Items]            
Number of units directly subscribed 9,545,456          
Purchase value of units $ 1.10          
Number of common shares included in unit 1          
Number of common share to purchase warrant included in unit 1          
Exercise price of warrants $ 1.10          
Purchase price of shares         13,460,000  
Purchase price of warrants         $ 7,540,000  
Number of additional common shares directly subscribed   1,740,000        
Purchase price of additional shares   $ 1.00        
Percentage of voting equity interests acquired         24.00%  
Investment cost capitalized         $ 38,000  
Percentage sale of current production         25.00%  
Term of Production to be sold         2 years  
Renewal Term of Production to Be Sold         1 year  
TerrAscend Corp | Canopy Rivers Corporation            
Disclosure Of Significant Investments In Associates [Line Items]            
Number of units indirectly subscribed 9,545,456          
Number of additional common shares indirectly subscribed   1,740,000        
Canopy Rivers Corporation            
Disclosure Of Significant Investments In Associates [Line Items]            
Percentage of debentures converted to common shares         23.80%  
Canopy Health Innovations Inc.            
Disclosure Of Significant Investments In Associates [Line Items]            
Percentage of voting equity interests acquired     46.15%   43.00% 0.00%
Investments in associates       $ 4,000,000    
Proceeds from issuing shares     $ 7,000,000 $ 8,842,000    
Bedrocan Brasil S.A.            
Disclosure Of Significant Investments In Associates [Line Items]            
Percentage of voting equity interests acquired         39.762%  
Entourage Phytolab S.A.            
Disclosure Of Significant Investments In Associates [Line Items]            
Percentage of voting equity interests acquired         39.99%